I think you can anticipate ‘25 being around expressing what our value is, what it takes to be Lilly, why we are different, why we care so much and how our values reflect in the way we approach ...

The bottom line: We're raising our Lilly fair value estimate to $620 from $580 to account for higher long-term growth from the oncology and immunology portfolio, which supports the firm's wide ...